Position in QGEN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$977,500
New position
Shares Held
25,000
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#164
of 332 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KORNITZER CAPITAL MANAGEMENT INC /KS holds $41,732,180 across 10 Diagnostics & Research names. QGEN ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
25,637 | $6,959,163 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
12,704 | $6,687,893 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
12,455 | $6,596,043 | |
| 4 | CSTL |
Castle Biosciences Inc
|
264,235 | $6,302,004 | |
| 5 | GH |
Guardant Health, Inc.
|
37,245 | $5,587,867 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
5,072 | $2,542,897 | |
| 7 | DHR |
Danaher Corp /De/
|
12,210 | $2,325,760 | |
| 8 | A |
Agilent Technologies, Inc.
|
16,075 | $2,135,242 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $977,500 | 25,000 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||